LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancerEliza Vakana, Louis F. Stancato|Oncotarget|2016Cited by 68
A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cellsCourtney M. Tate, Louis F. Stancato|Cell Death and Differentiation|2012Cited by 65
A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell BiologyCourtney M. Tate, Louis F. Stancato|PLoS ONE|2015Cited by 18